FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498397012 Tablet en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet Is a Unit of presentation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely furazolidone 100 milligram and metronidazole 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 200 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin 250 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 250 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin 775 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 775 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely darunavir (as darunavir ethanolate) 75 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely darunavir (as darunavir ethanolate) 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 90 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 90 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 67.5 milligram and artesunate 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 67.5 milligram and artesunate 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 67.5 milligram and artesunate 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 135 milligram and artesunate 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 135 milligram and artesunate 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 135 milligram and artesunate 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 270 milligram and artesunate 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 270 milligram and artesunate 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 270 milligram and artesunate 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely artesunate 100 milligram and mefloquine hydrochloride 220 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely artesunate 100 milligram and mefloquine hydrochloride 220 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artesunate 100 milligram and mefloquine hydrochloride 220 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely artesunate 60 milligram and pyronaridine tetraphosphate 180 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely artesunate 60 milligram and pyronaridine tetraphosphate 180 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artesunate 60 milligram and pyronaridine tetraphosphate 180 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely lamotrigine 2 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 2 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely lamotrigine 25 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 25 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely lamotrigine 100 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 100 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ethionamide 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ethionamide 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely diethylcarbamazine citrate 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely diethylcarbamazine citrate 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 4
Product containing precisely aspirin 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aspirin 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 153 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 153 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artesunate 25 milligram and mefloquine (as mefloquine hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely artesunate 25 milligram and mefloquine (as mefloquine hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artesunate 25 milligram and mefloquine (as mefloquine hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 76.5 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 76.5 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely artenimol 40 milligram and piperaquine phosphate 320 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely artenimol 40 milligram and piperaquine phosphate 320 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artenimol 40 milligram and piperaquine phosphate 320 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely diethylcarbamazine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely diethylcarbamazine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artenimol 20 milligram and piperaquine phosphate 160 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely artenimol 20 milligram and piperaquine phosphate 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely artenimol 20 milligram and piperaquine phosphate 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely benznidazole 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely benznidazole 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aspirin 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ivermectin 12 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ivermectin 12 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ivermectin 12 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely ivermectin 12 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely ethionamide 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier

Start Previous Page 76 of 153 Next End

This concept is not in any reference sets

Back to Start